Physician profile
Pratima V Kumar
NPI 1972558658
$506.93
in general payments reported to CMS, 2019-2025
10 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.89 · 2021: $50.71 · 2023: $7.35 · 2024: $107 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.38 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $129.46 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $79.19 | 2024-2025 | Omnipod |
| Ascendis Pharma Endocrinology INC | $66.20 | 2025 | Yorvipath |
| Novo Nordisk INC | $64.91 | 2021-2025 | Ozempic |
| Abbott Laboratories | $49.95 | 2025 | Freestyle Insulinx |
| Sequel Med Tech, LLC | $34.36 | 2025 | Twiist |
| Beta Bionics, INC. | $32.00 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amgen INC. | $19.97 | 2025 | Tepezza |
| Dexcom, INC. | $16.89 | 2019 | |
| Medtronic, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratima Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.